Carbon nanoparticles derived from a special oxidation of a variety of carbon rich sources are remarkably high capacity mimetics of superoxide dismutase, overcoming many limitations of conventional antioxidants while providing additional actions of considerable biological interest. Our prototype material is termed "pegylated hydrophilic carbon clusters", or PEG-HCCs. Since most injuries, especially ischemia/reperfusion, overwhelms endogenous antioxidant protection, these materials have applicability to a wide variety of pathologies. Moreover, their chemical structure attracts them to mitochondria, where we see an ability to shuttle electrons and therefore potentially overcome genetic or acquired disorders of mitochondrial electron transport. Our current work is directed at determining their mechanism of action in order to optimize their range of favorable properties, with the immediate goal to develop a therapy for human diseases of disorders of oxidative phosphorylation. A longer range goal is to determine their effect on progressive decline in brain function due to accumulation of oxidative injury to DNA and mitochondria.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
GCC Cluster NanoX
Appointments
Title
Department / School
Institution
Robert A. Welch Chair Professor
Institute of Biosciences and Technology
Institute of Biosciences and Technology -TAMHSC
Adjunct Professor
Chemistry
Rice Univ.
Adjunct Professor
Stanley H. Appel Department of Neurology and Methodist Research Institute
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.